Methodological aspects of diagnostics and minimal residual disease monitoring in infant acute leukemias

Hereby we present methodological aspects and prognostic significance of minimal residual disease (MRD) monitoring in infant acute leukemias. Based on our own experience we made algorithm for detection of MRD in this group of patients. We conclude that general concordance between MRD detection by flo...

Full description

Saved in:
Bibliographic Details
Main Authors: G. A. Tsaur, A. M. Popov, L. G. Fechina, S. A. Rumyantsev
Format: Article
Language:Russian
Published: ABV-press 2016-03-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/184
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689956960698368
author G. A. Tsaur
A. M. Popov
L. G. Fechina
S. A. Rumyantsev
author_facet G. A. Tsaur
A. M. Popov
L. G. Fechina
S. A. Rumyantsev
author_sort G. A. Tsaur
collection DOAJ
description Hereby we present methodological aspects and prognostic significance of minimal residual disease (MRD) monitoring in infant acute leukemias. Based on our own experience we made algorithm for detection of MRD in this group of patients. We conclude that general concordance between MRD detection by flow cytometry and real-time polymerase chain reaction (PCR) for fusion gene transcripts achieved 87.0 %. Concordance was significantly lower during induction in comparison to consolidation/intensification and relapse treatment (78.6; 90.4 and 93.4 %, correspondingly; p = 0.002). It was not dependent on presence of normal B-cell precursors. Concordance between MRD results obtained by qualitative real-time PCR in bone marrow and peripheral blood samples was 84.5 %. Interestingly, all discrepant results (22 samples 15.5 %) were MRD-positive in bone marrow, but negative in peripheral blood. Despite high qualitative concordance rate between MRD detection in bone marrow and peripheral blood samples we could not show prognostic value of MRD monitoring in peripheral blood by fusion gene transcripts. Multivariate analysis revealed that MRD-positivity at time-point 4 in bone marrow was the only significant and independent prognostic factor of unfavorable outcome in the observed group of patients (hazard ratio 7.326; 95 % confidence interval 2.378–22.565).
format Article
id doaj-art-ca411649a07a4dd487a5fc577366e509
institution DOAJ
issn 1818-8346
2413-4023
language Russian
publishDate 2016-03-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj-art-ca411649a07a4dd487a5fc577366e5092025-08-20T03:21:27ZrusABV-pressОнкогематология1818-83462413-40232016-03-01111627410.17650/1818-8346-2016-11-1-62-74192Methodological aspects of diagnostics and minimal residual disease monitoring in infant acute leukemiasG. A. Tsaur0A. M. Popov1L. G. Fechina2S. A. Rumyantsev3Regional Children Clinical Hospital No 1; 32 S. Deryabinoy St., Ekaterinburg, 620149, Russia Institute of Medical Cell Technologies; 22a Karla Marksa St., Ekaterinburg, 620026, Russia Ural Federal University named after the first President of Russia B. N. Yel’tsin; 19 Mira St., Ekaterinburg, 620002, RussiaFederal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia; 1 Samory Mashela St., Moscow, 117998, RussiaRegional Children Clinical Hospital No 1; 32 S. Deryabinoy St., Ekaterinburg, 620149, RussiaFederal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia; 1 Samory Mashela St., Moscow, 117998, Russia N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; 1 Ostrovityanova St., Moscow, 117997, RussiaHereby we present methodological aspects and prognostic significance of minimal residual disease (MRD) monitoring in infant acute leukemias. Based on our own experience we made algorithm for detection of MRD in this group of patients. We conclude that general concordance between MRD detection by flow cytometry and real-time polymerase chain reaction (PCR) for fusion gene transcripts achieved 87.0 %. Concordance was significantly lower during induction in comparison to consolidation/intensification and relapse treatment (78.6; 90.4 and 93.4 %, correspondingly; p = 0.002). It was not dependent on presence of normal B-cell precursors. Concordance between MRD results obtained by qualitative real-time PCR in bone marrow and peripheral blood samples was 84.5 %. Interestingly, all discrepant results (22 samples 15.5 %) were MRD-positive in bone marrow, but negative in peripheral blood. Despite high qualitative concordance rate between MRD detection in bone marrow and peripheral blood samples we could not show prognostic value of MRD monitoring in peripheral blood by fusion gene transcripts. Multivariate analysis revealed that MRD-positivity at time-point 4 in bone marrow was the only significant and independent prognostic factor of unfavorable outcome in the observed group of patients (hazard ratio 7.326; 95 % confidence interval 2.378–22.565).https://oncohematology.abvpress.ru/ongm/article/view/18411q23/mll rearrangementsinfant acute leukemiasminimal residual disease
spellingShingle G. A. Tsaur
A. M. Popov
L. G. Fechina
S. A. Rumyantsev
Methodological aspects of diagnostics and minimal residual disease monitoring in infant acute leukemias
Онкогематология
11q23/mll rearrangements
infant acute leukemias
minimal residual disease
title Methodological aspects of diagnostics and minimal residual disease monitoring in infant acute leukemias
title_full Methodological aspects of diagnostics and minimal residual disease monitoring in infant acute leukemias
title_fullStr Methodological aspects of diagnostics and minimal residual disease monitoring in infant acute leukemias
title_full_unstemmed Methodological aspects of diagnostics and minimal residual disease monitoring in infant acute leukemias
title_short Methodological aspects of diagnostics and minimal residual disease monitoring in infant acute leukemias
title_sort methodological aspects of diagnostics and minimal residual disease monitoring in infant acute leukemias
topic 11q23/mll rearrangements
infant acute leukemias
minimal residual disease
url https://oncohematology.abvpress.ru/ongm/article/view/184
work_keys_str_mv AT gatsaur methodologicalaspectsofdiagnosticsandminimalresidualdiseasemonitoringininfantacuteleukemias
AT ampopov methodologicalaspectsofdiagnosticsandminimalresidualdiseasemonitoringininfantacuteleukemias
AT lgfechina methodologicalaspectsofdiagnosticsandminimalresidualdiseasemonitoringininfantacuteleukemias
AT sarumyantsev methodologicalaspectsofdiagnosticsandminimalresidualdiseasemonitoringininfantacuteleukemias